Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Semaglutide for Sale > SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - large image1
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image1
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image2
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image3
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image4
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image5
SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30 buy - image6

SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30

TDS 492 Inquiries

Unit Price:

$41/UNIT FOB

Get Latest Price
CAS No.:

910463-68-2

Grade:

Research Grade

Content:

99%

Port:

Shengzhen

Brand:

KSD

Packaging:

30 mg/vial

Price valid (until):

2027-01-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  Shop SM10 Semaglutide-10-Detailed Image 1


    Physicochemical Properties and Product Characteristics
    SM10 is a synthetic peptide modified with specific fatty acid side chains, produced via solid-phase synthesis, sterile filtration, and low-temperature vacuum lyophilization. The finished product appears as a pure white, loose lyophilized cake; the powder is uniform in texture, dry, and fluffy, free from clumps, impurities, or irritating odors.
    Fragmentation or pulverization of the cake caused by vibration or jarring during transport is a normal physical phenomenon for lyophilized materials; this does not alter the molecular structure, purity, or experimental stability, nor does it affect standard scientific use.
    Upon complete dissolution in a sterile, bacteriostatic solvent, it forms a perfectly clear, colorless, and homogeneous liquid. The solution is stable—showing no turbidity, precipitation, flocculation, or phase separation—and meets the physicochemical standards for high-purity, research-grade peptide solutions.
    Exposure to open air for extended periods, repeated temperature fluctuations, or improper storage conditions may lead to signs of instability, such as a slight yellowing of the liquid, minor precipitation, or reduced transparency. In such cases, it is recommended to discontinue use to ensure the accuracy of control group data.

    Standard Storage Guidelines
    Lyophilized Powder: For long-term storage in a research setting, keep sealed and frozen at -20°C, protected from light, to maximize the stability of the molecular structure. For short-term experimental use (up to 3 months), the product may be stored sealed and refrigerated at 2°C–8°C, protected from light; avoid exposure to intense light, high temperatures, and humidity, and strictly minimize repeated freeze-thaw cycles.
    Reconstituted Solution: Once reconstituted into a clear solution, the product must be stored sealed and refrigerated at 2°C–8°C, protected from light; it is recommended to complete all experimental data collection within 28 days. Do not freeze the solution; low temperatures can damage the peptide's modified structure, leading to molecular denaturation, degradation, and experimental failure.

    Research on Receptor Binding and Molecular Signaling Mechanisms
    This product is suitable for *in vitro* peptide-receptor affinity assays, particularly for investigating the binding mode, binding stability, and signal activation processes associated with peptide molecules and their specific receptors. It serves as a control tool in fundamental research areas such as molecular biology, protein-protein interactions, and pathway activation mechanisms.
    2. Research on Cellular Energy Metabolism Pathways
    This product is applicable to *in vitro* cellular metabolic models, enabling the observation of how peptide factors influence cellular energy cycles, metabolic flux, and basal metabolic homeostasis. It is suitable for analyzing metabolic mechanisms and conducting multi-group gradient control experiments.

    3. Research on Cellular Glucose Metabolism Balance
    Suitable for *in vitro* experiments concerning cellular glucose uptake, transport, and metabolic balance; used to investigate the regulatory effects of peptide structures on cellular glucose metabolism systems and to provide experimental data supporting academic research into metabolic mechanisms.
    4. Fundamental Research on Lipid Metabolism Mechanisms
    Applicable to *in vitro* cellular models of lipid metabolism; used to study the impact of peptide signaling on lipid synthesis, transport, and metabolic cycling, particularly in research focused on metabolic balance and material flux.
    5. Comparative Research on Peptide Structure-Activity Relationships
    SM10 features a fatty acid modification, conferring superior molecular stability and resistance to degradation. It frequently serves as the long-acting modified peptide in experimental groups—compared against standard short-chain or unmodified peptides—to analyze how molecular modification influences stability, solubility, and resistance to breakdown; it is a common starting material for research into peptide structural optimization.

    Items Specifications
    SM2 2 mg/vial,10vial/kit
    SM10 10 mg/vial,10vial/kit
    SM30 30 mg/vial,10vial/kit
    Shop SM30 Semaglutide-30-Detailed Image 2 Shop SM10-Peptide Product SM30 Semaglutide-30 semaglutide-30 SM-30-Detailed Image 3

    Shop SM10 Semaglutide-10-Detailed Image 3 Shop SM10 Semaglutide-10-Detailed Image 4

    ECHEMI Editorial Reference
    Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
    Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
    The story of semaglutide began in the 1980s when scientists (such as Joel Habener and Jens Juul Holst) discovered GLP-1, a hormone in the human body that regulates blood sugar and appetite. However, its highly degradable nature limited its potential for medicinal use. In the 1990s, researchers at Novo Nordisk in Denmark, including Lotte Bjerre Knudsen, drew inspiration from the Gila monster's venom protein Exendin-4 and successfully developed the first GLP-1 drug, exenatide. In pursuit of a longer-acting drug, the Novo Nordisk team, led by Knudsen, created a once-daily liraglutide in the 2000s by structurally modifying human GLP-1 and adding fatty acid chains. Building on this success, the team further optimized the formula, ultimately leading to the development of semaglutide, with a longer half-life, by scientists including a research team led by Mads Krogsgaard Thomsen. It was approved in 2017 as a once-weekly blood sugar lowering drug (Ozempic), and in 2021 it shocked the world with its remarkable effects in the field of weight loss (Wegovy), evolving from a scientific concept into a benchmark drug that changes the treatment of metabolic diseases.
    ChEBI: Semaglutide is a polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide-1 receptors (GLP-1 AR) and used for the treatment of type 2 diabetes. It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist, an anti-obesity agent, a neuroprotective agent and an appetite depressant. It is a polypeptide and a lipopeptide.
    Semaglutide Synthetic is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 4113 Dalton and a Molecular formula of C187H291N45O59.

    Certificates

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide Injection

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    Licheng District, Jinan City, Shandong Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

    Certifications:

    Retatrutide coa

    Hello and welcome to learn about Kangshengda Biotechnology! We are a specialized enterprise dedicated to the R&D and production of peptide products. Leveraging high-quality peptide preparations, our core strength lies in supporting customers to achieve long-term weight management and all-round health regulation.
    Boasting extensive mature export experience, our products are sold to Europe, the United States and numerous other countries and regions worldwide. Supported by consistent, reliable product quality, efficient on-time delivery and a comprehensive professional after-sales service system, we have built long-term, solid strategic partnerships with overseas distributors.
    We are committed to delivering one-stop customized premium peptide solutions for all clients, and seek long-term development and win-win cooperation alongside domestic and global partners!
    KSD
    ">KSD
  • Inquiry History
    492 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Weight Loss Semaglutide intermediate 99% White powder COA High Quality peptide GLP-1 910463-68-2

    5 MG Apr 11, 2024
    United States

    Gene-Biocon Semaglutide 910463-68-2 GLP-1analogs diabetes weight loss 96% White or off-white powder

    Dec 5, 2023
    United States

    Semaglutide 910463-68-2

    1 G Sep 21, 2023
    United States

    Sermaglutide 99% 910463-68-2

    2 KG Oct 21, 2023
    China

    Semaglutide CAS 910463-68-2

    1 KG Apr 16, 2026
    United Kingdom

    TGYFactory Supply Semaglutide Peptide 99% CAS 910463-68-2

    50 MT Nov 13, 2023
    Sri Lanka

    Bulk Supply 98% up Sermaglutide powder CAS 910463-68-2

    300 G Nov 18, 2023
    United States

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    500 G Oct 9, 2023
    United States

    Raw mateiral Semaglutide CAS 910463-68-2 99% White powder

    1000 G Sep 23, 2023
    Switzerland

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    5000 MT Sep 13, 2023
    United States

    High Purity Peptide Semaglutide 910463-68-2 With Safe Shipping

    1 G Sep 7, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    60 MG Aug 4, 2025
    United States

    10MG vial pack Semaglutide 99% 910463-68-2 GLP-1 Peptide

    10 MT Oct 18, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10 MT Sep 19, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    Nov 13, 2024
    United States

    semaglutide CAS 910463-68-2 in stock 2-4 days safe delivery

    1 MT Nov 4, 2023
    United Kingdom

    API Pharmaceutical Chemical Grade Raw Materials CAS 910463-68-2 Semaglutide

    40 MT Sep 27, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10  Sep 27, 2023
    China

    Semaglutide Tirzepatide for Weight Loss CAS: 910463-68-2 Retatrutide Cagrilintide

    1 MT Jul 5, 2025
    India

    Best Price 99% Semaglutide Peptide 10mg Vials Semaglutide CAS 910463-68-2

    100  Nov 8, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.